AMSilk, based in Munich, focuses on developing sustainable silk protein materials using bio-fabrication techniques. Unlike traditional silk or synthetic materials, their products offer high performance with a lower environmental footprint, addressing a significant gap in current material technologies. Their B2B model positions them to supply various industries, particularly in health tech and manufacturing. With backing from investors like Novo A/S, AMSilk has the financial support to expand its operations. Their unique approach differentiates them from competitors and aligns with the demand for eco-friendly, high-quality materials.